Revotar Biopharmaceuticals AG
3 clinical trials · Sponsor
◉ Watch Revotar Biopharmaceuticals AG
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy Study of Bimosiamose Cream to Treat Psoriasis (NCT00823693) | Revotar Biopharmaceuticals AG | |
| Study to Evaluate Safety and Efficacy of Inhaled Bimosiamose for the Treatment of Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (NCT01108913) | Revotar Biopharmaceuticals AG | |
| Study to Evaluate the Effect of Bimosiamose on Ozone Induced Sputum Neutrophilia (NCT00962481) | Revotar Biopharmaceuticals AG |
Track Revotar Biopharmaceuticals AG automatically
Every clearance here is in the API, with alerts when new ones post.